ClinicalTrials.govpublic full text
Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors
advanced solid tumours with androgen receptor pathway as a potential factor, solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827956
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.